Latin America Generic Drug Market

Latin America Generic Drug Market Development, Trends, Demand and Forecast Till 2021-2026

According to IMARC Group’s latest report, titled “Latin America Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the market is expected to exhibit strong growth during 2021-2026. A generic drug represents a drug formulation that is similar to a branded drug in terms of dosage, strength, side effects, efficiency, etc. It is developed after the patent on the original drug expires and can differ from its branded counterparts when it comes to size, shape, color, packaging, etc. Some of the common examples of generic drugs include paracetamol, amoxicillin, ofloxacin, etc. These drugs are sold at lower prices as they do not require extensive clinical studies to demonstrate their effectiveness. As a result, they are used in hospitals and pharmacies across Latin America.

Request for a PDF sample of this report:

The escalating incidences of individuals with Alzheimer’s disease, osteoarthritis, rheumatoid arthritis, etc., are among the key factors driving the Latin America generic drug market. In line with this, the elevating number of patent expirations is further stimulating the market growth. Moreover, the rising investments by government bodies and NGOs in domestic drug manufacturing and healthcare infrastructures are also augmenting the regional market. Besides this, the increasing adoption of licensing and partnering strategies by leading manufacturers to launch newer versions of pharmaceutical products is acting as another significant growth-inducing factor. Additionally, the development of several product variants, such as anti-infective drugs, anti-arthritis drugs, central nervous system drugs, etc., is anticipated to fuel the Latin America generic drug market over the forecasted period. Looking forward, IMARC Group expects the global market to continue its robust growth during the forecast period (2021-2026).

Checkout Now:

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Market Segmentation:

Breakup by Segment:

  • Unbranded Generics
  • Branded Generics

Breakup by Therapy Area:

  • Central Nervous System
  • Cardiovascular
  • Dermatology
  • Genitourinary/Hormonal
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others

Breakup by Drug Delivery:

  • Oral
  • Injectables
  • Dermal/Topical
  • Inhalers

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies

Breakup by Country:

  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Chile
  • Peru
  • Others

Ask Analyst for Customization and Explore full report with TOC & List of Figures:

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2021-2026) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                    

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:


30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Response